{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T12:44:29Z","timestamp":1794660269722,"version":"4.9.1"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.ygyno.2026.07.009","type":"journal-article","created":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T13:28:40Z","timestamp":1784122120000},"page":"200-207","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["\u201cI was in the driver's seat\u201d: A qualitative analysis of factors promoting and delaying previvors' oophorectomy after risk-reducing salpingectomy"],"prefix":"10.1016","volume":"211","author":[{"given":"Isabel","family":"Chess","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharonne","family":"Holtzman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madison","family":"Cox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jayme","family":"Leschly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Gellman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie V.","family":"Blank","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2026.07.009_bb0005","series-title":"Cancer Stat Facts","author":"Cancer of the Ovary","year":"2026"},{"key":"10.1016\/j.ygyno.2026.07.009_bb0010","series-title":"Genetic\/Familial High-Risk Assessment: Breast, Ovarian, Pancreatic, and Prostate: NCCN Guidelines","year":"2026"},{"issue":"22","key":"10.1016\/j.ygyno.2026.07.009_bb0015","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1001\/jama.2011.766","article-title":"Effect of screening on ovarian cancer mortality: the prostate, lung, colorectal and ovarian (PLCO) cancer screening randomized controlled trial","volume":"305","author":"Buys","year":"2011","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.ygyno.2026.07.009_bb0020","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1001\/jama.2017.21926","article-title":"Screening for ovarian cancer: US preventive services task force recommendation statement","volume":"319","author":"US Preventive Services Task Force","year":"2018","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.ygyno.2026.07.009_bb0030","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1093\/jnci\/djn442","article-title":"Meta-analysis of risk reduction estimates associated with risk-reducing salpingo-oophorectomy in BRCA1 or BRCA2 mutation carriers","volume":"101","author":"Rebbeck","year":"2009","journal-title":"J. Natl. Cancer Inst."},{"issue":"3","key":"10.1016\/j.ygyno.2026.07.009_bb0035","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S1470-2045(06)70585-X","article-title":"Mortality after bilateral salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers: a prospective cohort study","volume":"7","author":"Domchek","year":"2006","journal-title":"Lancet Oncol."},{"issue":"9","key":"10.1016\/j.ygyno.2026.07.009_bb0040","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1001\/jama.2010.1237","article-title":"Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality","volume":"304","author":"Domchek","year":"2010","journal-title":"JAMA"},{"issue":"15","key":"10.1016\/j.ygyno.2026.07.009_bb0045","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1200\/JCO.2013.53.2820","article-title":"Impact of oophorectomy on cancer incidence and mortality in women with a BRCA1 or BRCA2 mutation","volume":"32","author":"Finch","year":"2014","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"issue":"12","key":"10.1016\/j.ygyno.2026.07.009_bb0050","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1111\/1471-0528.17511","article-title":"Care after premenopausal risk-reducing salpingo-oophorectomy in high-risk women: scoping review and international consensus recommendations","volume":"130","author":"Nebgen","year":"2023","journal-title":"BJOG"},{"issue":"2","key":"10.1016\/j.ygyno.2026.07.009_bb0055","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.3390\/curroncol30020185","article-title":"The psychosocial impact of the decision to undergo risk-reducing Salpingo-oophorectomy surgery in BRCA mutation carriers and the role of physician-patient communication","volume":"30","author":"Alves-Nogueira","year":"2023","journal-title":"Curr. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2026.07.009_bb0060","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1002\/pon.2041","article-title":"The impact of prophylactic salpingo-oophorectomy on quality of life and psychological distress in women with a BRCA mutation","volume":"22","author":"Finch","year":"2013","journal-title":"Psychooncology"},{"issue":"2","key":"10.1016\/j.ygyno.2026.07.009_bb0065","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.ygyno.2014.02.030","article-title":"Acceptability of prophylactic salpingectomy with delayed oophorectomy as risk-reducing surgery among BRCA mutation carriers","volume":"133","author":"Holman","year":"2014","journal-title":"Gynecol. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2026.07.009_bb0075","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.ygyno.2019.06.017","article-title":"Reproductive and hormonal considerations in women at increased risk for hereditary gynecologic cancers: Society of Gynecologic Oncology and American Society for reproductive medicine evidence-based review","volume":"155","author":"Chen","year":"2019","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2026.07.009_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.maturitas.2026.108886","article-title":"Development of cardiovascular risk factors in women with a BRCA1\/2 pathogenic variant within five years after tubo-ovarian cancer risk reduction in the TUBA study","volume":"207","author":"Gootzen","year":"2026","journal-title":"Maturitas"},{"issue":"1","key":"10.1016\/j.ygyno.2026.07.009_bb0085","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ygyno.2018.12.014","article-title":"Hormone replacement therapy after risk reducing salpingo-oophorectomy in patients with BRCA1 or BRCA2 mutations; a systematic review of risks and benefits","volume":"153","author":"Gordhandas","year":"2019","journal-title":"Gynecol. Oncol."},{"issue":"5","key":"10.1016\/j.ygyno.2026.07.009_bb0090","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.ajog.2013.04.019","article-title":"The role of the fallopian tube in the origin of ovarian cancer","volume":"209","author":"Erickson","year":"2013","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"3","key":"10.1016\/j.ygyno.2026.07.009_bb0095","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/PAS.0b013e3181cf3d79","article-title":"The origin and pathogenesis of epithelial ovarian Cancer: a proposed unifying theory","volume":"34","author":"Kurman","year":"2010","journal-title":"Am. J. Surg. Pathol."},{"issue":"25","key":"10.1016\/j.ygyno.2026.07.009_bb0100","doi-asserted-by":"crossref","first-page":"3985","DOI":"10.1200\/JCO.2007.12.2622","article-title":"Primary fallopian tube malignancies in BRCA-positive women undergoing surgery for ovarian cancer risk reduction","volume":"25","author":"Callahan","year":"2007","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2026.07.009_bb0105","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/GCO.0b013e328011a21f","article-title":"The distal fallopian tube: a new model for pelvic serous carcinogenesis","volume":"19","author":"Crum","year":"2007","journal-title":"Curr. Opin. Obstet. Gynecol."},{"issue":"1","key":"10.1016\/j.ygyno.2026.07.009_bb0110","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/AOG.0b013e3182783c2f","article-title":"Prophylactic salpingectomy and delayed oophorectomy as an alternative for BRCA mutation carriers","volume":"121","author":"Kwon","year":"2013","journal-title":"Obstet. Gynecol."},{"issue":"3","key":"10.1016\/j.ygyno.2026.07.009_bb0115","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.ygyno.2011.02.012","article-title":"Radical fimbriectomy: a reasonable temporary risk-reducing surgery for selected women with a germ line mutation of BRCA 1 or 2 genes? Rationale and preliminary development","volume":"121","author":"Leblanc","year":"2011","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2026.07.009_bb0120","author":"M.D Anderson Cancer Center"},{"key":"10.1016\/j.ygyno.2026.07.009_bb0125","author":"Hullu"},{"issue":"2","key":"10.1016\/j.ygyno.2026.07.009_bb0130","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1136\/ijgc-2020-001541","article-title":"Preventing ovarian cancer through early excision of tubes and late ovarian removal (PROTECTOR): protocol for a prospective non-randomised multi-center trial","volume":"31","author":"Gaba","year":"2021","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"4","key":"10.1016\/j.ygyno.2026.07.009_bb0135","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.ajog.2025.10.044","article-title":"Salpingectomy in individuals at high risk for tubo-ovarian cancer: consensus and precaution","volume":"234","author":"Wilke","year":"2026","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"2","key":"10.1016\/j.ygyno.2026.07.009_bb0140","first-page":"122","article-title":"Surgical decision making in premenopausal BRCA carriers considering risk-reducing early salpingectomy or salpingo-oophorectomy: a qualitative study","volume":"59","author":"Gaba","year":"2022","journal-title":"J. Med. Genet."},{"issue":"2","key":"10.1016\/j.ygyno.2026.07.009_bb0145","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.ygyno.2014.12.031","article-title":"Risk-reducing salpingectomy with delayed oophorectomy in BRCA1\/2 mutation carriers: patients\u2019 and professionals\u2019 perspectives","volume":"136","author":"Arts-de Jong","year":"2015","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2026.07.009_bb0150","article-title":"\u201cIt was a no-brainer\u201d: a qualitative study of factors driving previvors\u2019 decision-making when considering risk-reducing salpingectomy with delayed oophorectomy","volume":"40","author":"Gellman","year":"2022","journal-title":"Gynecol Oncol Rep."},{"key":"10.1016\/j.ygyno.2026.07.009_bb0155","series-title":"The Wiley Encyclopedia of Health Psychology","first-page":"211","article-title":"Gryboski K. The Health Belief Model","author":"Green","year":"2020"},{"key":"10.1016\/j.ygyno.2026.07.009_bb0160","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ygyno.2023.04.006","article-title":"Patient perspectives on risk-reducing salpingectomy with delayed oophorectomy for ovarian cancer risk-reduction: a systematic review of the literature","volume":"173","author":"Perez","year":"2023","journal-title":"Gynecol. Oncol."},{"issue":"7","key":"10.1016\/j.ygyno.2026.07.009_bb0165","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1097\/GME.0000000000002201","article-title":"Barriers to hormone therapy following prophylactic bilateral salpingo-oophorectomy in BRCA1\/2 mutation carriers","volume":"30","author":"DiSilvestro","year":"2023","journal-title":"Menopause"},{"issue":"2","key":"10.1016\/j.ygyno.2026.07.009_bb0170","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s10689-020-00166-5","article-title":"Perceptions of risk and reward in BRCA1 and BRCA2 mutation carriers choosing salpingectomy for ovarian cancer prevention","volume":"19","author":"Ghezelayagh","year":"2020","journal-title":"Fam. Cancer"},{"key":"10.1016\/j.ygyno.2026.07.009_bb0175","author":"NRG Oncology"},{"issue":"13","key":"10.1016\/j.ygyno.2026.07.009_bb0180","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1002\/cncr.30621","article-title":"Racial disparities in BRCA testing and cancer risk management across a population-based sample of young breast cancer survivors","volume":"123","author":"Cragun","year":"2017","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2026.07.009_bb0190","series-title":"Health Behaviour and Health Education; Theory, Research, and Practice","first-page":"45","article-title":"The Health Belief Model","author":"Champion","year":"2008"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825826020627?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825826020627?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T00:35:55Z","timestamp":1786149355000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825826020627"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":35,"alternative-id":["S0090825826020627"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2026.07.009","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"\u201cI was in the driver's seat\u201d: A qualitative analysis of factors promoting and delaying previvors' oophorectomy after risk-reducing salpingectomy","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2026.07.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}